Puntel, M., Muhammad, A. K., Candolfi, M., Salem, A., Yagiz, K., Farrokhi, C., . . . Castro, M. G. (2010).,
A novel bicistronic high-capacity gutless adenovirus vector that drives constitutive expression of herpes simplex virus type 1 thymidine kinase and tet-inducible expression of Flt3L for glioma therapeutics., Journal of Virology, 84(12), 6007-6017. doi:10.1128/JVI.00398-10 [doi]
King, G. D., Muhammad, A. K., Larocque, D., Kelson, K. R., Xiong, W., Liu, C., . . . Lowenstein, P. R. (2011).,
Combined Flt3L/TK gene therapy induces immunological surveillance which mediates an immune response against a surrogate brain tumor neoantigen., Molecular Therapy : The Journal of the American Society of Gene Therapy, 19(10), 1793-1801. doi:10.1038/mt.2011.77 [doi]
King, G. D., Muhammad, A. K., Curtin, J. F., Barcia, C., Puntel, M., Liu, C., . . . Castro, M. G. (2008).,
Flt3L and TK gene therapy eradicate multifocal glioma in a syngeneic glioblastoma model., Neuro-Oncology, 10(1), 19-31. doi:15228517-2007-045 [pii]
King, G. D., Kroeger, K. M., Bresee, C. J., Candolfi, M., Liu, C., Manalo, C. M., . . . Castro, M. G. (2008).,
Flt3L in combination with HSV1-TK-mediated gene therapy reverses brain tumor-induced behavioral deficits., Molecular Therapy : The Journal of the American Society of Gene Therapy, 16(4), 682-690. doi:10.1038/mt.2008.18 [doi]
Baker, G. J., Yadav, V. N., Motsch, S., Koschmann, C., Calinescu, A. A., Mineharu, Y., . . . Lowenstein, P. R. (2014),
Mechanisms of glioma formation: Iterative perivascular glioma growth and invasion leads to tumor progression, VEGF-independent vascularization, and resistance to antiangiogenic therapy., Neoplasia (New York, N.Y.), 16(7), 543-561. doi:10.1016/j.neo.2014.06.003 [doi]
Pool, S. E., ten Hagen, T. L., Koelewijn, S., de Jong, M., & Koning, G. A. (2012).,
Multimodality imaging of somatostatin receptor-positive tumors with nuclear and bioluminescence imaging.,分子成像,11(1),27-32。
Baker, G. J., Chockley, P., Yadav, V. N., Doherty, R., Ritt, M., Sivaramakrishnan, S., . . . Lowenstein, P. R. (2014).,
Natural killer cells eradicate galectin-1-deficient glioma in the absence of adaptive immunity., Cancer Research, 74(18), 5079-5090. doi:10.1158/0008-5472.CAN-14-1203 [doi]
Bison, S. M., Pool, S. E., Koelewijn, S. J., van der Graaf, L. M., Groen, H. C., Melis, M., & de Jong, M. (2014).,
肽受体放射性核素治疗(PRRT)与[(177)Lu-dota(0),tyr(3)]偶数与Rad001治疗组合:进一步研究大鼠胰腺CA20948肿瘤模型中的肿瘤转移和反应。, EJNMMI Research, 4, 21-014-0021-y. eCollection 2014. doi:10.1186/s13550-014-0021-y [doi]
Bison, S. M., Pool, S. E., Koelewijn, S. J., van der Graaf, L. M., Groen, H. C., Melis, M., & de Jong, M. (2014).,
肽受体放射性核素治疗(PRRT)与[(177)Lu-dota(0),tyr(3)]偶数与Rad001治疗组合:进一步研究大鼠胰腺CA20948肿瘤模型中的肿瘤转移和反应。, EJNMMI Research, 4, 21-014-0021-y. eCollection 2014. doi:10.1186/s13550-014-0021-y [doi]
Jacobs, V. L., Landry, R. P., Liu, Y., Romero-Sandoval, E. A., & De Leo, J. A. (2012).,
Propentofylline decreases tumor growth in a rodent model of glioblastoma multiforme by a direct mechanism on microglia., Neuro-Oncology, 14(2), 119-131. doi:10.1093/neuonc/nor194 [doi]
Poli, A., Wang, J., Domingues, O., Planaguma, J., Yan, T., Rygh, C. B., . . . Chekenya, M. (2013).,
Targeting glioblastoma with NK cells and mAb against NG2/CSPG4 prolongs animal survival.,oncotarget,4(9),1527-1546。DOI:1291 [PII]